Early Relief of Upper Gastrointestinal Dyspeptic Symptoms: A Survey of Empirical Therapy with Pantoprazole in Canadian Clinical Practice
BACKGROUND: Upper gastrointestinal symptoms attributable to gastroesophageal reflux disease or peptic ulcer are common, but the outcome of proton pump inhibitor therapy in clinical practice is not well documented.
Saved in:
Main Authors: | David Armstrong, Farouk Kazim, Marcel Gervais, Myron Pyzyk |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2002-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2002/567684 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Potential of Pantoprazole in Treatment and Prevention of Gastrointestinal Diseases
by: A. A. Sheptulin, et al.
Published: (2021-04-01) -
A One-Year Economic Evaluation of Six Alternative Strategies for the Management of Uninvestigated Upper Gastrointestinal Symptoms in Canadian Primary Care
by: Alan N Barkun, et al.
Published: (2010-01-01) -
Validation of the GSFQ, a Self-Administered Symptom Frequency Questionnaire for Patients with Gastroesophageal Reflux Disease
by: Pierre Paré, et al.
Published: (2003-01-01) -
Gastritis Stages in Monozygotic and Dizygotic Dyspeptic Twins
by: Mindaugas Urba, et al.
Published: (2020-01-01) -
Pantoprazole – safety in drug-drug interaction
by: E. V. Shikh, et al.
Published: (2012-09-01)